IS5594A - Lyfjablanda sem inniheldur gerandefni angíótensínII viðtaka af gerð 2 og notkun hennar - Google Patents
Lyfjablanda sem inniheldur gerandefni angíótensínII viðtaka af gerð 2 og notkun hennarInfo
- Publication number
- IS5594A IS5594A IS5594A IS5594A IS5594A IS 5594 A IS5594 A IS 5594A IS 5594 A IS5594 A IS 5594A IS 5594 A IS5594 A IS 5594A IS 5594 A IS5594 A IS 5594A
- Authority
- IS
- Iceland
- Prior art keywords
- receptor
- angiotensin
- pharmaceutical composition
- composition containing
- receptor agonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9800550A SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
PCT/SE1999/000262 WO1999043339A1 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IS5594A true IS5594A (is) | 2000-08-21 |
Family
ID=20410283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5594A IS5594A (is) | 1998-02-24 | 2000-08-21 | Lyfjablanda sem inniheldur gerandefni angíótensínII viðtaka af gerð 2 og notkun hennar |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1066048A1 (es) |
JP (1) | JP2002504516A (es) |
KR (1) | KR20010041211A (es) |
CN (1) | CN1291104A (es) |
AU (1) | AU755949B2 (es) |
BR (1) | BR9908188A (es) |
CA (1) | CA2319123A1 (es) |
EE (1) | EE200000481A (es) |
HU (1) | HUP0101411A3 (es) |
ID (1) | ID26639A (es) |
IL (1) | IL137990A0 (es) |
IS (1) | IS5594A (es) |
MX (1) | MXPA00008172A (es) |
NO (1) | NO20004215L (es) |
NZ (1) | NZ506188A (es) |
SE (1) | SE9800550D0 (es) |
SK (1) | SK11522000A3 (es) |
WO (1) | WO1999043339A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001043761A2 (en) * | 1999-12-16 | 2001-06-21 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
US6821953B1 (en) | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
CA2449150C (en) | 2001-05-31 | 2011-07-12 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
KR101429484B1 (ko) | 2005-04-12 | 2014-08-13 | 바이코어 파마 아베 | 신규한 트리시클릭 안지오텐신 ⅱ 아고니스트 |
AU2006235706B2 (en) | 2005-04-12 | 2012-03-08 | Vicore Pharma Ab | New tricyclic angiotensin II agonists |
ES2582945T3 (es) | 2005-04-12 | 2016-09-16 | Vicore Pharma Ab | Nuevos agonistas bicíclicos de angiotensina II |
KR101423898B1 (ko) * | 2005-12-14 | 2014-07-28 | 암브룩스, 인코포레이티드 | 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도 |
US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
EP2455388A1 (en) | 2010-11-23 | 2012-05-23 | LanthioPep B.V. | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
US20150119329A1 (en) * | 2012-04-16 | 2015-04-30 | New York University | Modulation of angiotensin ii receptors for the prevention and treatment of malaria cerebral |
AU2016227486A1 (en) | 2015-03-02 | 2017-08-17 | Vicore Pharma Ab | Angiotensin ll receptor agonist for treating pulmonary fibrosis |
WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
GB201818164D0 (en) | 2018-11-07 | 2018-12-19 | Vicore Pharma Ab | New composition |
WO2021023698A1 (en) | 2019-08-02 | 2021-02-11 | Lanthiopep B.V | Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer |
GB201913603D0 (en) | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
AU2021238939A1 (en) | 2020-03-19 | 2022-11-10 | Vicore Pharma Ab | Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition associated with angiotensin II |
GB202004094D0 (en) | 2020-03-20 | 2020-05-06 | Vicore Pharma Ab | New compounds and uses |
GB202006079D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
GB202006081D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
GB202006074D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
GB202013721D0 (en) | 2020-09-01 | 2020-10-14 | Vicore Pharma Ab | New compounds |
GB202104033D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
US20240182461A1 (en) | 2021-03-23 | 2024-06-06 | Vicore Pharma Ab | Selective angiotensin ii receptor ligands |
GB202104038D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
JP2024523576A (ja) | 2021-07-09 | 2024-06-28 | ヴィコール ファルマ アーベー | 新規の選択的アンジオテンシンii化合物 |
GB202115303D0 (en) | 2021-10-25 | 2021-12-08 | Vicore Pharma Ab | New formulation |
WO2023152503A1 (en) | 2022-02-10 | 2023-08-17 | Vicore Pharma Ab | Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis |
GB202201723D0 (en) | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
WO2024133942A1 (en) | 2022-12-22 | 2024-06-27 | Vicore Pharma Ab | A method of treating a patient diagnosed with an interstitial lung disease |
WO2024149712A1 (en) | 2023-01-09 | 2024-07-18 | Vicore Pharma Ab | Selective angiotensin ii compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5444067A (en) * | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
AU3708295A (en) * | 1994-11-04 | 1996-05-31 | Stefan L. Marklund | Use of receptor agonists to stimulate superoxide dismutase activity |
SE9501881D0 (sv) * | 1995-05-19 | 1995-05-19 | Astra Ab | New pharmacological use of AII-receptor antagonists |
US5834432A (en) * | 1995-06-06 | 1998-11-10 | The University Of Southern California | Use of angiotensin II Type 2 receptor agonists in tissue repair |
SE9502219D0 (sv) * | 1995-06-19 | 1995-06-19 | Astra Ab | Novel medical use |
-
1998
- 1998-02-24 SE SE9800550A patent/SE9800550D0/xx unknown
-
1999
- 1999-02-24 ID IDW20001909A patent/ID26639A/id unknown
- 1999-02-24 KR KR1020007009295A patent/KR20010041211A/ko not_active Application Discontinuation
- 1999-02-24 MX MXPA00008172A patent/MXPA00008172A/es unknown
- 1999-02-24 HU HU0101411A patent/HUP0101411A3/hu unknown
- 1999-02-24 EP EP99908017A patent/EP1066048A1/en not_active Withdrawn
- 1999-02-24 JP JP2000533135A patent/JP2002504516A/ja active Pending
- 1999-02-24 IL IL13799099A patent/IL137990A0/xx unknown
- 1999-02-24 SK SK1152-2000A patent/SK11522000A3/sk unknown
- 1999-02-24 AU AU27537/99A patent/AU755949B2/en not_active Ceased
- 1999-02-24 CA CA002319123A patent/CA2319123A1/en not_active Abandoned
- 1999-02-24 BR BR9908188-1A patent/BR9908188A/pt not_active IP Right Cessation
- 1999-02-24 WO PCT/SE1999/000262 patent/WO1999043339A1/en not_active Application Discontinuation
- 1999-02-24 NZ NZ506188A patent/NZ506188A/xx unknown
- 1999-02-24 CN CN99803230A patent/CN1291104A/zh active Pending
- 1999-02-24 EE EEP200000481A patent/EE200000481A/xx unknown
-
2000
- 2000-08-21 IS IS5594A patent/IS5594A/is unknown
- 2000-08-23 NO NO20004215A patent/NO20004215L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1066048A1 (en) | 2001-01-10 |
KR20010041211A (ko) | 2001-05-15 |
HUP0101411A2 (hu) | 2002-03-28 |
AU2753799A (en) | 1999-09-15 |
ID26639A (id) | 2001-01-25 |
SK11522000A3 (sk) | 2001-04-09 |
WO1999043339A1 (en) | 1999-09-02 |
IL137990A0 (en) | 2001-10-31 |
CN1291104A (zh) | 2001-04-11 |
JP2002504516A (ja) | 2002-02-12 |
BR9908188A (pt) | 2000-10-24 |
EE200000481A (et) | 2002-02-15 |
NO20004215L (no) | 2000-09-18 |
HUP0101411A3 (en) | 2002-11-28 |
MXPA00008172A (es) | 2002-06-21 |
CA2319123A1 (en) | 1999-09-02 |
NZ506188A (en) | 2003-04-29 |
NO20004215D0 (no) | 2000-08-23 |
AU755949B2 (en) | 2003-01-02 |
SE9800550D0 (sv) | 1998-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS5594A (is) | Lyfjablanda sem inniheldur gerandefni angíótensínII viðtaka af gerð 2 og notkun hennar | |
HUP0301083A3 (en) | Synergistical herbicide composition and use thereof | |
HUP0201545A2 (en) | Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them | |
NO20012411D0 (no) | Pyrrolidin-derivater-CCR-3-reseptorantagonister | |
IS5794A (is) | Lyfjasamsetning sem inniheldur COX-2-hemil og iNOS-hemil | |
NO20032753D0 (no) | Forbindelse og anvendelse derav | |
DK0945132T3 (da) | Ibuprofen-præparat | |
HUP0104270A3 (en) | Herbicidal composition and use thereof | |
HUP0003217A3 (en) | Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and pharmaceutical compositions containing them | |
ID27415A (id) | Komposisi farmaseutik | |
EP1112252A4 (en) | KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF | |
NO20006488D0 (no) | Sammensetning og anvendelse | |
ID29262A (id) | Komposisi farmasi | |
IL139865A0 (en) | A liver selective glucocorticoid antagonist and pharmaceutical compositions containing the same | |
NO20010804L (no) | Muskariniske agonister og antagonister | |
NO20004274L (no) | Proteaseaktivert reseptor 4 og anvendelse derav | |
DE69806641D1 (de) | Vernetzbare verfilmende zusammensetzung | |
HUP0402178A3 (en) | Pharmaceutical composition comprising a 5 hti receptor agonist | |
IL138576A0 (en) | A novel interleukin-1 receptor antagonist and uses thereof | |
ID20466A (id) | Komposisi oral | |
NO20012943D0 (no) | Nye heterocykliske forbindelser og farmasöytiske sammensetninger inneholdende det samme | |
GB9820014D0 (en) | Receptor antagonists and uses thereof | |
BR9710568A (pt) | Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2 | |
ID26215A (id) | Komposisi farmasi | |
DE69923065D1 (de) | Fluorcopolymer und zusammensetzung daraus |